Corporate Members

The Pennsylvania Society of Oncology and Hematology expresses its gratitude to our corporate members. Donations from the following companies help us in fulfilling our mission.

To learn more about becoming a Corporate Member, please click here.


10k Members

Bristol Myers Squibb


About Us: At Bristol Myers Squibb, we work every day to transform patients’ lives through science. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.  We are proud of the advancements we have made in oncology, hematology, immunology and cardiovascular disease, and we are dedicated to helping patients prevail over serious diseases through our diverse and promising pipeline and new scientific platforms. We are pursuing therapies at the forefront of scientific discovery with the goal of bringing an exciting new generation of life-changing treatments to patients. We aspire to be at the center of a vibrant healthcare innovation ecosystem, where academic research centers, biotech and biopharma companies all contribute to continued scientific advancement.  During this unprecedented time, if you have U.S. patients who have lost jobs and health insurance due to COVID-19, we will o¬≠ffer our covered medicines at no cost. For a complete list of our covered medicines, patients can call 1-800-721-8909 or visit www.bms.com to learn more.

Website:
www.bms.com

Representative Contacts: 
Patrick Curtin, Patrick.Curtin@bms.com, 908-420-7093

Social Media:
Twitter: https://twitter.com/BMSNEWS
LinkedIn: https://www.linkedin.com/company/bristol-myers-squibb/
Instagram: https://www.instagram.com/bristolmyerssquibb/

Facebook: https://www.facebook.com/BristolMyersSquibb
YouTube: https://www.youtube.com/bristolmyerssquibb


Daiichi-Sankyo

About us: The mission of Daiichi Sankyo Cancer Enterprise is to leverage our world-class, innovative science and push beyond traditional thinking to create meaningful treatments for patients with cancer. We are dedicated to transforming science into value for patients, and this sense of obligation informs everything we do. Anchored by our DXd antibody drug conjugate (ADC) technology, our powerful research engines include biologics, medicinal chemistry, modality and other research laboratories in Japan, and Plexxikon Inc., our small molecule structure-guided R&D center in Berkeley, CA. For more information, please visit: www.DSCancerEnterprise.com.

Website: www.DSCancerEnterprise.com ; www.dsi.com

Representative Contact:
Dan Pagana, dpagana@dsi.com, 570-974-1860

Social Media:
Twitter: https://twitter.com/DaiichiSankyoUS
LinkedIn: https://www.linkedin.com/company/daiichi-sankyo/


Immunomedics

About Us: Immunomedics is a leader in next generation antibody-drug conjugate (ADC) technology, committed to helping transform the lives of people with hard-to-treat cancers.

Website: https://www.immunomedics.com/

Representatives:
Rep contact:
Stephen Gardner, Oncology Account Manager: Sgardner@immunomedics.com 412 2160075

Director of National Accounts:
Nicole Cornett: NCornett@immunomedics.com 2013414605
 

Social Media:
LinkedIn: https://www.linkedin.com/company/immunomedics/
Facebook: https://www.facebook.com/immunomedics/
Twitter: https://twitter.com/ImmunomedicsInc


Seagen Inc.

About Us: Seagen Inc. is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. We are leveraging our expertise in antibodies to build a portfolio of proprietary immuno-oncology agents in clinical trials for hematologic malignancies and solid tumors. For more information, visit www.seagen.com.

Click here to learn more.

Website: www.seagen.com; https://www.seagen.com/medicines

Social Media:
LinkedIn: https://www.linkedin.com/company/seagen
Twitter: https://twitter.com/seagenglobal


5k Members


Exelixis, Inc., 


About us: Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines. To ensure you have the latest clinical data, including links to our pivotal trial publications, and important product information, visit our website.

Website: https://www.exelixis.com

Representative:

Michael Nozzi
Senior Oncology Account Manager
570-357-1906
mnozzi@exelixis.com


Natera


About us: Natera is a pioneer and global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, cancer researchers, biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn

Website: www.natera.com/oncology

Representatives:

Mike Weber, Clinical Oncology Specialist, Greater Philadelphia: mweber@natera.com (215) 630-6505

Jonathan Liess, Clinical Oncology Specialist, Greater Allentown: jliess@natera.com (215) 279-1033

Cynthia Los, Clinical Oncology Specialist, Southeastern PA, DE & MD: clos@natera.com (443) 622-7072

Lydia Hammond, Clinical Oncology Specialist, Greater Harrisburg: lhammond@natera.com (507) 261-9537

Tiffany Stein, Clinical Oncology Specialist, Greater Pittsburgh: tstein@natera.com (412) 980-0763

Social Media:
Facebook: https://www.facebook.com/NateraGenetics/
Twitter: https://twitter.com/NateraOncology
LinkedIn: https://www.linkedin.com/company/natera
YouTube: https://www.youtube.com/watch?v=NnmuCPnr9vM


Pfizer Oncology


Representatives:

Sue Sproat, CPC, CHONC, CMR, Field Reimbursement Manager - MD, DC, DE, PA
410-627-0807 (cell) | 484-323-7995 (fax)
susan.r.sproat@pfizer.com



Sanofi Genzyme

About us: Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Learn more at www.sanofigenzyme.com.

Website: www.sanofigenzyme.com

Representatives:

Nanette Rutherford, Field Reimbursement Manager
724-708-6495
nanette.rutherford@sanofi.com

Social Media:
Facebook: https://www.facebook.com/SanofiGenzyme/
LinkedIn: https://www.linkedin.com/company/sanofigenzyme/
Twitter: https://twitter.com/SanofiGenzyme

CareASSIST Patient Support Information:

Advertisement
About CareASSIST

Our Corporate Members

Pennsylvania Society of Oncology and Hematology
400 Winding Creek Blvd.
Mechanicsburg, PA 17050
(833) 770-1553
info@psoh.org

Our Corporate Members

This website brought to you by:

Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds